Exagen Inc.
XGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $56 | $53 | $46 | $48 |
| % Growth | 5.9% | 15.3% | -5.7% | – |
| Cost of Goods Sold | $23 | $23 | $24 | $21 |
| Gross Profit | $33 | $29 | $21 | $28 |
| % Margin | 59.5% | 56.1% | 46.9% | 57.4% |
| R&D Expenses | $5 | $5 | $10 | $7 |
| G&A Expenses | $40 | $46 | $0 | $43 |
| SG&A Expenses | $41 | $47 | $52 | $45 |
| Sales & Mktg Exp. | $1 | $2 | $0 | $2 |
| Other Operating Expenses | $0 | $0 | $6 | $0 |
| Operating Expenses | $47 | $52 | $67 | $52 |
| Operating Income | -$14 | -$23 | -$46 | -$24 |
| % Margin | -24.5% | -43.5% | -101.1% | -49.8% |
| Other Income/Exp. Net | -$1 | -$1 | -$2 | -$3 |
| Pre-Tax Income | -$15 | -$24 | -$48 | -$27 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$15 | -$24 | -$47 | -$27 |
| % Margin | -27.2% | -45.1% | -104% | -55.6% |
| EPS | -0.83 | -1.34 | -2.77 | -1.68 |
| % Growth | 38.1% | 51.6% | -64.9% | – |
| EPS Diluted | -0.83 | -1.34 | -2.77 | -1.68 |
| Weighted Avg Shares Out | 18 | 18 | 17 | 16 |
| Weighted Avg Shares Out Dil | 18 | 18 | 17 | 16 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $2 | $1 | $0 |
| Interest Expense | $2 | $2 | $2 | $3 |
| Depreciation & Amortization | $2 | $2 | $2 | $1 |
| EBITDA | -$11 | -$19 | -$44 | -$23 |
| % Margin | -20% | -36.4% | -95.8% | -47.8% |